Risks of parenteral deferoxamine for acute iron poisoning.
about
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercuryPharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In VivoPreconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathyDeferoxamine toxicity in hepatoma and primary rat cortical brain cultures.Pharmacological priming of adipose-derived stem cells for paracrine VEGF production with deferoxamine.Acute iron poisoning in adult female.
P2860
Risks of parenteral deferoxamine for acute iron poisoning.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Risks of parenteral deferoxamine for acute iron poisoning.
@en
type
label
Risks of parenteral deferoxamine for acute iron poisoning.
@en
prefLabel
Risks of parenteral deferoxamine for acute iron poisoning.
@en
P2860
P1476
Risks of parenteral deferoxamine for acute iron poisoning.
@en
P2093
Howland MA
P2860
P304
P356
10.3109/15563659609028006
P577
1996-01-01T00:00:00Z